Vimarsana
Biggest News Aggregation in the World

Page 2 - Jack Anders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jack Anders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jack Anders Today - Breaking & Trending Today

Insider Selling: Revolution Medicines, Inc. (NASDAQ:RVMD) CFO Sells $400,300.00 in Stock - Vimarsana News

Insider Selling: Revolution Medicines, Inc. (NASDAQ:RVMD) CFO Sells $400,300.00 in Stock

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) CFO Jack Anders sold 10,000 shares of Revolution Medicines stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $40.03, for a total value of $400,300.00. Following the completion of the transaction, the chief financial officer now directly […]

Revolution Medicines (RVMD) Scheduled to Post Earnings on Wednesday - Vimarsana News

Revolution Medicines (RVMD) Scheduled to Post Earnings on Wednesday

Revolution Medicines (NASDAQ:RVMD – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.75) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link. Revolution […]

Source: wkrb13.com
Revolution Medicines (NASDAQ:RVMD) PT Raised to $45.00 - Vimarsana News

Revolution Medicines (NASDAQ:RVMD) PT Raised to $45.00

Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price upped by Oppenheimer from $43.00 to $45.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price target points to a potential upside of 20.29% from the company’s current […]

Revolution Medicines (NASDAQ:RVMD) Upgraded to "Strong-Buy" at Raymond James - Vimarsana News

Revolution Medicines (NASDAQ:RVMD) Upgraded to "Strong-Buy" at Raymond James

Revolution Medicines (NASDAQ:RVMD – Get Free Report) was upgraded by equities research analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a note issued to investors on Wednesday, MarketBeat reports. The brokerage presently has a $48.00 target price on the stock, up from their prior target price of $36.00. Raymond James’ […]

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Rating of "Buy" by Brokerages - Vimarsana News

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Rating of "Buy" by Brokerages

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has received a consensus rating of “Buy” from the ten research firms that are covering the company, Marketbeat reports. Ten analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have issued a report on the stock in the last […]